Top Markets
#1 Black Phoenix Black Phoenix +167.48%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +43.60%
#5 Cryptopia Cryptopia +20.92%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.51%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#8 Test Test +17.66%
#9 Victoria VR Victoria VR +12.65%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +10.37%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Genomic Vision S.A. Genomic Vision S.A.

Genomic Vision S.A.

GV
Classifica tra le azioni #41547
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A.... Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.
Prezzo delle azioni
$0.00196068
Ultima sincronizzazione: 2023-12-01
Capitalizzazione di mercato
$16.64K
Variazione (1 giorno)
0.01%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Genomic Vision S.A. (GV)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Genomic Vision S.A. (GV)
L’azione Genomic Vision S.A. (simbolo: GV) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 13, 2026.
Una quota di GV acquistata prima di Aug 13, 2026 equivale oggi a 0 quote di GV.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 8 x34
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 7 x47
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 0 -
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 4 x15
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 0 -
US